Eric Brandt
Disclosed holdings of Eric Brandt as of 2026-06-12: 145K shares of Lam Research (LRCX), worth about $34.6M at the last close and 3 other companies. In 12…
What Eric Brandt reported holding
As of the latest filing on , Eric Brandt reported holding 144,705 shares of Lam Research (LRCX), worth about $34.6M at the last close of $239 (Oct 30, 2026). Holdings are also on file at Gen Digital (GEN), Option Care Health (OPCH), Nutanix (NTNX); together they are worth about $38.3M. In the last 12 months, Eric Brandt sold $47M in 45 sales.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Lam Research LRCX | 144,705 | 145K direct | $239 | $34.6M | Jun 12, 2026 |
| Gen Digital GEN | 87,578 | 9,072 direct · 79K the brandt family trust | $29 | $2.55M | Sep 9, 2026 |
| Option Care Health OPCH | 21,999 | 22K direct | $32 | $700K | May 20, 2026 |
| Nutanix NTNX | 6,698 | 6,698 direct | $67 | $450K | Dec 12, 2025 |
Is this Eric Brandt’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2009
Eric Brandt bought shares on the open market in 2009, and has not bought since 2009 across 3 companies. Sales in 10 of the 18 years since 2009.
Eric Brandt reported 1 open-market purchase and 56 sales since 2009; purchases in 2009.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | 45×45 trades |
| 2023 | — | 1×1 trade |
| 2022 | — | 1×1 trade |
| 2021 | — | 1×1 trade |
| 2020 | — | 1×1 trade |
| 2019 | — | 1×1 trade |
| 2018 | — | 2×2 trades |
| 2017 | — | 2×2 trades |
| 2013 | — | 1×1 trade |
| 2009 | 1×1 trade | 1×1 trade |
Insider at 3 companies
- Lam Research LRCX2026 · 0 purchases, 45 sales
- Dentsply Sirona XRAY2009–2023 · 1 purchase, 10 sales
- Vertex Pharmaceuticals VRTX2009 · 0 purchases, 1 sale
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Lam Research LRCX
Eric Brandt reported 0 open-market purchases and 45 sales here, 2026.
- Market value
- $299B
- Last close
- $239.11
- 12 months
- +48.5%
- Against the S&P 500
- +37.3 pts
- Net margin
- 31.3%
- Revenue (last year)
- $23.2B
- Dentsply Sirona XRAY
Eric Brandt reported 1 open-market purchase and 10 sales here, 2009 to 2023.
- Market value
- $1.9B
- Last close
- $9.53
- 12 months
- −24.3%
- Against the S&P 500
- −35.5 pts
- Net margin
- -16.3%
- Revenue (last year)
- $3.68B
- Vertex Pharmaceuticals VRTX
Eric Brandt reported 0 open-market purchases and 1 sale here, 2009.
- Market value
- $142B
- Last close
- $558.88
- 12 months
- +33.1%
- Against the S&P 500
- +21.9 pts
- Net margin
- 32.9%
- Revenue (last year)
- $12B
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Eric Brandt's trades
Has Eric Brandt bought shares on the open market?
Eric Brandt bought shares on the open market in 2009, and has not bought since 2009 across 3 companies. Sales in 10 of the 18 years since 2009.
When did Eric Brandt last buy or sell shares?
In SEC filings since 2009: the latest open-market purchase is from 2009; the latest open-market sale is from 2026.
Which companies has Eric Brandt traded as an insider?
3 companies: Lam Research (LRCX, 2026), Dentsply Sirona (XRAY, 2009–2023), Vertex Pharmaceuticals (VRTX, 2009).